Cardiovascular Associates of East Texas
Tyler, Texas 75702
0 studies enrolling now · 16 studies all time
What they study most
Angina Pectoris, Arterial Occlusive Diseases, Bradycardia, Cardiovascular Disease, Cardiovascular Diseases, Coronary Artery Disease, Critical Limb Ischemia, Heart Disease, Heart Failure, High Cardiovascular Risk, Obesity, Optim Lead Insulation Related Adverse Events
Studies at this site
- Observational Study to Evaluate PAD Treatment Clinical and Economic Outcomes — Completed
- Pantheris Atherectomy Treatment of In-Stent Restenosis In Lower Extremity Arteries — Completed
- Evaluation of the FreedomFlow™ Orbital Atherectomy System to Treat Peripheral Artery Disease — Completed
- Tack Optimized Balloon Angioplasty Study of the Tack Endovascular System® in Below the Knee Arteries — Completed
- Evaluation of Safety and Effectiveness of the BioMimics 3D Stent System — Completed
- Lead Registry for Optim Leads — Completed
- St. Jude Medical Product Longevity and Performance (SCORE) Registry — Completed
- ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients — Stopped early
- Revolution™ Peripheral Atherectomy System for Lower Extremity Peripheral Arterial Revascularization — Completed
- The OPC for Optimal Delivery of Paclitaxel for the Prevention of Endovascular Restenosis - Above and Below the Knee — Completed
- QuickFlex Micro Left Ventricular Lead Post Approval Study — Completed
- A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors — Completed
- The COPPER-B Trial — Completed
- Angiogenesis in Women With Angina Pectoris Who Are Not Candidates for Revascularization — Status unconfirmed
- SPIROCOR Coronary Outcome by Respiratory Stress Examination — Stopped early
- To Find the Best Dose of pVGI.1(VEGF2) to Benefit Angina Patients When Given With an Experimental Injection Catheter — Status unconfirmed